These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26386274)

  • 1. Intralesional Interferon-α2b Improves Penile Curvature in Peyronie's Disease.
    Milam DF
    J Urol; 2015 Dec; 194(6):1533. PubMed ID: 26386274
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
    Lacy GL; Adams DM; Hellstrom WJ
    Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
    Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
    J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease.
    Trost LW; Ates E; Powers M; Sikka S; Hellstrom WJ
    J Urol; 2013 Dec; 190(6):2194-9. PubMed ID: 23688848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsurgical management of Peyronie's disease--are we making any progress?
    Meacham RB
    J Urol; 2006 Jul; 176(1):12-3. PubMed ID: 16753356
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
    Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
    J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
    Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
    Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease.
    Yafi FA; Hatzichristodoulou G; Knoedler CJ; Trost LW; Sikka SC; Hellstrom WJ
    J Sex Med; 2015 Dec; 12(12):2492-8. PubMed ID: 26646187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
    Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
    J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
    Judge IS; Wisniewski ZS
    Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic corticosteroid treatment in Peyronie's disease.
    Uzun H
    Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyronie's disease: review and recent advances.
    Langston JP; Carson CC
    Maturitas; 2014 Aug; 78(4):341-3. PubMed ID: 24984940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peyronie's disease: treatment with interferon and laser].
    Candebat Montero LH; Miranda Reyes PL; Díaz García F; González Ferro I; Barbosa Ramos F; Codorniu Furet J
    Arch Esp Urol; 2008 Apr; 61(3):413-23. PubMed ID: 18581679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.